T
Thomas C. Merigan
Researcher at Stanford University
Publications - 515
Citations - 34283
Thomas C. Merigan is an academic researcher from Stanford University. The author has contributed to research in topics: Interferon & Virus. The author has an hindex of 98, co-authored 514 publications receiving 33941 citations. Previous affiliations of Thomas C. Merigan include University of Arizona & Rockefeller Institute of Government.
Papers
More filters
Journal ArticleDOI
Durability of Response to Treatment among Antiretroviral-Experienced Subjects: 48-Week Results from AIDS Clinical Trials Group Protocol 359
Roy M. Gulick,X. Joan Hu,X. Joan Hu,Susan A. Fiscus,Courtney V. Fletcher,Richard Haubrich,Hailong Cheng,Hailong Cheng,Edward P. Acosta,Stephen W. Lagakos,Ronald Swanstrom,William W. Freimuth,William W. Freimuth,Sally Snyder,Charlotte Mills,Margaret A. Fischl,Carla Pettinelli,Carla Pettinelli,David Katzenstein,David Katzenstein,Charles J. Gonzalez,Olivia T. Ortiz,Richard Hutt,Candida T. Talabucon,Janine R. Maenza,Rebecca Becker,D. Baker,Andrea Weiss,Robert Kalajian,Margaret Nelson,Kim Ingersol,Michael S. Saag,Sherree Wright,Tammy Powell,Pamposh Kaul,Donna Thee,Judith Feinberg,Joseph Wheat,Kristine Todd,Linda Meixner,Bruce Coon,Douglas D. Richman,Neel French,Joseph Pulvirenti,Harold A. Kessler,Jim Bruce,Aouie Carrera,Michael J. Borucki,John Fuchs,Karen Waterman,Joseph J. Eron,Charles van der Horst,Linh Ngo,Janet Devine,M. Graham Ray,Beverly Putnam,Suzanne Fiorillo,John G. Gerber,Jane L. Norris,Debbie Slamowitz,Thomas C. Merigan,Harvey M. Friedman,Doris Shank,Chris Helker,Daniel C. Rodrigue,Frances Canchola,John M. Leedom,Liliana Aguinada,Scott A. Smith,Timothy W. Schacker,Henry S. Sacks,Alice F. Mercado,Hilda Mendoza,Steve Nowling,David Pearson,Laura Ponticello,Michael F. Giordano,Brenda Greenhill,Jorge Santana,Guillermo J. Vázquez,Ileana Lopez,Virginia Ramirez,Mary Albrecht,Don Craven,Andrea Christopher Belschner,Michael F. Para,Robert J. Fass,Jan Clark,Charles B. Hicks,Paulette Mac Dougall,Stuart Carr,Mary Shoemaker,Ross G. Hewitt,Susan E. Cohn,Juan J.L. Lertora,Mark A. Beilke,David M. Mushatt,Russell Strada,Gildon N. Beall,Dena Duran,Mario Guerrero,Mark A. Jacobson,Judy Aberg,Glenna M. Auerback,Phyllis Barnett,Pablo Tebas,Genice Hamilton,Michael Royal,Lyle Oshita,Monica Millard,Scott Souza,Debra Ogata-Arakaki,Robert Delapenha,John Mc Neil,Lisa Alexis,Judith Brown,Elizabeth Gimbel,Ann Walawander,Kenneth Wood,Jeff Taylor,Bruce Peel,Jon Cook,Carol L. Brosgart,James F. Rooney,Cheryl N. Karol,Pascal J. de Caprariis,Jeanne Berg,Margo Heath-Chiozzi,Eugene Sun,Mark I. Becker,Ana Martinez,Robin Shepard,Melissa Kerkau,Joan Dragavon,Michelle Jack,Vivian Yuan,Robert W. Coombs,Antoinette Kenton,Sharon Shriver,Hongyu Jiang +139 more
TL;DR: Results show that some patients who experience treatment failure can demonstrate durable virologic and immunologic responses with salvage antiretroviral regimens.
Patent
Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen
TL;DR: In this article, the authors used PICLC to induce interferon in the host, achieving a serum level of 50 units per milliliter or higher for effective clinical treatment and 17 × 10 4 - 6.0 × 10 3 U/kg/day is an effective dose for exogenous interference.
Journal ArticleDOI
Uncertain role of cytosine arabinoside in varicella infection of compromised hosts
TL;DR: This report summarizes the authors' experience with cytosine a'rabinoside in varicella zoster infections and concludes that the therapeutic results were favorable.